-
Product Insights
Prostaglandin E2 Receptor EP4 Subtype – Drugs In Development, 2023
Global Markets Direct’s Prostaglandin E2 Receptor EP4 Subtype provides in depth analysis on Prostaglandin E2 Receptor EP4 Subtype targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Prostaglandin...
-
Product Insights
Prostaglandin E2 Receptor EP1 Subtype – Drugs In Development, 2023
Global Markets Direct’s Prostaglandin E2 Receptor EP1 Subtype provides in depth analysis on Prostaglandin E2 Receptor EP1 Subtype targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Prostaglandin...
-
Product Insights
Yunlin E2 Solar PV Park
Yunlin E2 Solar PV Park is a solar PV project located in Yunlin County, Taiwan. The project is owned and developed by Vena Energy Pte Ltd. The project came online in 2022. Empower your strategies with our Yunlin E2 Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CHIKV-VLP in Chikungunya Fever
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CHIKV-VLP in Chikungunya Fever report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CHIKV-VLP in Chikungunya Fever Drug Details: CHIKV-VLP is under development for the prevention...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MBF-362 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MBF-362 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MBF-362 in Solid Tumor Drug Details: MBF-362 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GUR-701 in Androgenic Alopecia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GUR-701 in Androgenic Alopecia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GUR-701 in Androgenic Alopecia Drug Details: GUR-701 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LX-1001 in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LX-1001 in Alzheimer's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LX-1001 in Alzheimer's Disease Drug Details: LX-1001 is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – JVGL-1 in Ocular Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - JVGL-1 in Ocular Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.JVGL-1 in Ocular Hypertension Drug Details:JVGL-1 is under development for the treatment of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – JVGL-1 in Open-Angle Glaucoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - JVGL-1 in Open-Angle Glaucoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.JVGL-1 in Open-Angle Glaucoma Drug Details:JVGL-1 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CR-6086 in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CR-6086 in Metastatic Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CR-6086 in Metastatic Colorectal Cancer Drug Details: CR-6086 is under...